Bayesian optimization identifies a methane-combustion catalyst formula
Bayesian optimization guided the experimental search over Pt/Pd and Ce/Zr ratios in PtPd@CeZrOx core–shell nanospheres. The authors report that two optimization rounds comprising 18 experiments found a formula with methane-conversion T50 approaching 330 °C, lower than prior reports cited by the study. The full assay conditions and comparison basis were not reviewed here; this is a bounded laboratory result, not a claim of general superiority, durability, or deployment.
Technology: Bayesian optimization for experimental catalyst-formula selection
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The publisher abstract reports that BO guided two experimental optimization rounds (18 experiments total) and that the selected PtPd@CeZrOx formula reached a methane-conversion T50 approaching 330 °C.
- Still unknown: Full test conditions, exact comparator basis, replicate variability and durability were not assessed in this abstract-limited review. The reported T50 does not establish field emissions performance or general superiority.
- AI role: Bayesian optimization selected multi-component Pt/Pd and Ce/Zr catalyst-formula ratios across iterative experiments; the reported T50 is the measured outcome associated with the selected formula.
Evidence sources: https://onlinelibrary.wiley.com/doi/10.1002/anie.202313068 · https://pubmed.ncbi.nlm.nih.gov/37823845/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary Wiley publisher abstract/indexed article text and PubMed primary metadata/abstract read. Full article Methods/Results and supporting information were not accessible..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.